(2,4,5-trichlorophenoxy)acetic acid decreases expression ISO Fkbp5 (Mus musculus) 6480464 2 more ... CTD PMID:18579281 1,2-dimethylhydrazine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FKBP5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO Fkbp5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of FKBP5 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of FKBP5 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol increases expression ISO FKBP5 (Homo sapiens) 6480464 Estradiol results in increased expression of FKBP5 mRNA CTD PMID:31614463 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FKBP5 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO Fkbp5 (Mus musculus) 6480464 Estradiol results in increased expression of FKBP5 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA and Estradiol inhibits the reaction [[Bucladesine co-treated with fulvestrant] results in decreased expression of FKBP5 mRNA] CTD PMID:19693291 and PMID:26427651 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of FKBP5 mRNA] CTD PMID:21440447 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO FKBP5 (Homo sapiens) 6480464 Metribolone results in increased expression of FKBP5 mRNA and Metribolone results in increased expression of FKBP5 protein CTD PMID:16751804 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO FKBP5 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of FKBP5 mRNA CTD PMID:18007998 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FKBP5 mRNA CTD PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FKBP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FKBP5 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FKBP5 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO FKBP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of FKBP5 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FKBP5 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FKBP5 mRNA CTD PMID:19770486 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of FKBP5 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of FKBP5 mRNA CTD PMID:21346803 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Fkbp5 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3,3',5,5'-tetrabromobisphenol A increases expression ISO Fkbp5 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of FKBP5 mRNA CTD PMID:30496566 3,5,6-trichloro-2-pyridinol multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 3,5,6-trichloropyridine-2-one multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FKBP5 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FKBP5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FKBP5 mRNA CTD PMID:28628672 3-phenoxybenzoic acid multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 3H-1,2-dithiole-3-thione increases expression ISO Fkbp5 (Mus musculus) 6480464 1 and 2-dithiol-3-thione results in increased expression of FKBP5 mRNA CTD PMID:15375163 4,4'-diaminodiphenylmethane increases expression ISO Fkbp5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FKBP5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FKBP5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO FKBP5 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FKBP5 protein CTD PMID:34186270 5-fluorouracil multiple interactions ISO FKBP5 (Homo sapiens) 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of FKBP5 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of FKBP5 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of FKBP5 mRNA CTD PMID:31881176 acrylamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Acrylamide results in decreased expression of FKBP5 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO FKBP5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of FKBP5 gene CTD PMID:27153756 aldrin decreases expression ISO Fkbp5 (Mus musculus) 6480464 Aldrin results in decreased expression of FKBP5 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO FKBP5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of FKBP5 mRNA CTD PMID:15498508 more ... amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FKBP5 mRNA CTD PMID:30779732 amphotericin B decreases expression ISO FKBP5 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of FKBP5 mRNA CTD PMID:28534445 antimycin A increases expression ISO FKBP5 (Homo sapiens) 6480464 Antimycin A results in increased expression of FKBP5 mRNA CTD PMID:33512557 arsane multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic inhibits the reaction [Progesterone results in increased expression of FKBP5 mRNA] CTD PMID:33047385 arsane decreases expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic results in decreased expression of FKBP5 mRNA CTD PMID:33047385 arsenic atom multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic inhibits the reaction [Progesterone results in increased expression of FKBP5 mRNA] CTD PMID:33047385 arsenic atom decreases expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic results in decreased expression of FKBP5 mRNA CTD PMID:33047385 arsenous acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FKBP5 protein] CTD PMID:26598702 arsenous acid affects expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of FKBP5 mRNA CTD PMID:25873331 atazanavir sulfate multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA CTD PMID:32152650 atazanavir sulfate decreases expression ISO FKBP5 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of FKBP5 mRNA CTD PMID:32152650 atenolol decreases expression ISO FKBP5 (Homo sapiens) 6480464 Atenolol results in decreased expression of FKBP5 mRNA CTD PMID:19915711 Aurin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 aurin inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] and aurin inhibits the reaction [NR3C1 protein results in increased expression of FKBP5 mRNA] CTD PMID:19255438 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 benzene increases expression ISO FKBP5 (Homo sapiens) 6480464 Benzene results in increased expression of FKBP5 protein CTD PMID:15036117 benzo[a]pyrene decreases expression ISO Fkbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FKBP5 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO FKBP5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of FKBP5 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO FKBP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FKBP5 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO Fkbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of FKBP5 exon and Benzo(a)pyrene results in increased methylation of FKBP5 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO Fkbp5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FKBP5 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO FKBP5 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FKBP5 mRNA CTD PMID:18164116 bicalutamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 bicalutamide results in decreased expression of FKBP5 mRNA CTD PMID:28500234 bicalutamide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA CTD PMID:28500234 bis(2-chloroethyl) sulfide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Mustard Gas results in increased alkylation of Dexamethasone] which results in increased expression of FKBP5 mRNA CTD PMID:31515601 bis(2-ethylhexyl) phthalate increases expression ISO Fkbp5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of FKBP5 mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate increases expression ISO FKBP5 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of FKBP5 protein CTD PMID:31163220 bisphenol A decreases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of FKBP5 mRNA and bisphenol A results in decreased expression of FKBP5 protein CTD PMID:18007998 more ... bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FKBP5 intron CTD PMID:26427651 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FKBP5 mRNA and bisphenol A results in decreased expression of FKBP5 protein CTD PMID:26427651 and PMID:34947998 bisphenol A multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [bisphenol A co-treated with Bucladesine] results in increased methylation of FKBP5 intron more ... CTD PMID:26427651 and PMID:32518293 bisphenol A increases expression ISO Fkbp5 (Mus musculus) 6480464 bisphenol A results in increased expression of FKBP5 mRNA CTD PMID:25594700 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FKBP5 mRNA CTD PMID:24988533 more ... Bisphenol B increases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol B results in increased expression of FKBP5 protein CTD PMID:34186270 bisphenol F increases expression ISO FKBP5 (Homo sapiens) 6480464 bisphenol F results in increased expression of FKBP5 protein CTD PMID:34186270 bortezomib decreases expression ISO FKBP5 (Homo sapiens) 6480464 Bortezomib results in decreased expression of FKBP5 mRNA CTD PMID:20977926 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of FKBP5 mRNA CTD PMID:32479839 bucladesine multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [bisphenol A co-treated with Bucladesine] results in increased methylation of FKBP5 intron more ... CTD PMID:26427651 buta-1,3-diene increases expression ISO Fkbp5 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of FKBP5 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of FKBP5 mRNA CTD PMID:29432896 Butylbenzyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of FKBP5 mRNA CTD PMID:19167457 cadmium dichloride decreases expression ISO FKBP5 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of FKBP5 mRNA CTD PMID:18560533 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FKBP5 mRNA CTD PMID:25993096 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of FKBP5 mRNA CTD PMID:22110744 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of FKBP5 promoter CTD PMID:22457795 caffeine increases phosphorylation ISO FKBP5 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of FKBP5 protein CTD PMID:35688186 calcitriol increases expression ISO FKBP5 (Homo sapiens) 6480464 Calcitriol results in increased expression of FKBP5 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FKBP5 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO Fkbp5 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of FKBP5 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Fkbp5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 carmustine increases expression EXP 6480464 Carmustine results in increased expression of FKBP5 mRNA CTD PMID:16005536 CCCP multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and affects the localization of PINK1 protein] promotes the reaction [FKBP5 protein binds to PINK1 protein] CTD PMID:30734931 CGP 52608 multiple interactions ISO FKBP5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FKBP5 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 chlordecone increases expression ISO Fkbp5 (Mus musculus) 6480464 Chlordecone results in increased expression of FKBP5 mRNA CTD PMID:33711761 chloroethene decreases expression ISO Fkbp5 (Mus musculus) 6480464 Vinyl Chloride results in decreased expression of FKBP5 mRNA CTD PMID:18579281 chloroprene increases expression ISO Fkbp5 (Mus musculus) 6480464 Chloroprene results in increased expression of FKBP5 mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of FKBP5 mRNA CTD PMID:23125180 chlorpromazine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Chlorpromazine inhibits the reaction [Lipopolysaccharides results in decreased expression of FKBP5 protein] CTD PMID:21034739 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 ciclopirox multiple interactions ISO FKBP5 (Homo sapiens) 6480464 ciclopirox inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:19255438 ciguatoxin CTX1B affects expression ISO Fkbp5 (Mus musculus) 6480464 Ciguatoxins affects the expression of FKBP5 mRNA CTD PMID:18353800 clofibrate decreases expression ISO Fkbp5 (Mus musculus) 6480464 Clofibrate results in decreased expression of FKBP5 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO FKBP5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of FKBP5 mRNA CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FKBP5 mRNA CTD PMID:24386269 colforsin daropate hydrochloride multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Colforsin promotes the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:19255438 copper atom multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FKBP5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of FKBP5 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO FKBP5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of FKBP5 mRNA CTD PMID:19549813 copper(II) sulfate decreases expression ISO Fkbp5 (Mus musculus) 6480464 Copper Sulfate results in decreased expression of FKBP5 mRNA CTD PMID:18579281 corticosterone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] CTD PMID:31344373 corticosterone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Corticosterone results in decreased expression of FKBP5 mRNA CTD PMID:31344373 cortisol increases expression ISO FKBP5 (Homo sapiens) 6480464 Hydrocortisone results in increased expression of FKBP5 mRNA CTD PMID:21267416 coumestrol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA CTD PMID:19167446 coumestrol increases expression ISO FKBP5 (Homo sapiens) 6480464 Coumestrol results in increased expression of FKBP5 mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FKBP5 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO FKBP5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FKBP5 mRNA CTD PMID:20106945 and PMID:32152650 cyclosporin A multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA CTD PMID:32152650 dapsone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of FKBP5 mRNA] CTD PMID:21440447 DDE multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 deoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 dexamethasone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] more ... CTD PMID:17690134 more ... dexamethasone increases expression ISO FKBP5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of FKBP5 mRNA and Dexamethasone results in increased expression of FKBP5 protein CTD PMID:12732289 more ... dexamethasone increases expression ISO Fkbp5 (Mus musculus) 6480464 Dexamethasone results in increased expression of FKBP5 mRNA CTD PMID:22733784 more ... dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:20032058 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of FKBP5 mRNA CTD PMID:20032058 more ... dexamethasone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Bucladesine co-treated with Dexamethasone] results in increased expression of FKBP5 mRNA more ... CTD PMID:16054899 more ... diarsenic trioxide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FKBP5 protein] CTD PMID:26598702 diarsenic trioxide affects expression ISO FKBP5 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of FKBP5 mRNA CTD PMID:25873331 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FKBP5 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FKBP5 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO Fkbp5 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of FKBP5 mRNA CTD PMID:28962523 diethyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 Diisodecyl phthalate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3 more ... CTD PMID:32518293 dimethylarsinic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA CTD PMID:23192986 dioxygen multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FKBP5 mRNA CTD PMID:30529165 diquat increases expression ISO Fkbp5 (Mus musculus) 6480464 Diquat results in increased expression of FKBP5 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 FKBP5 protein affects the reaction [Doxorubicin results in increased degradation of and results in decreased expression of NFKBIA protein] CTD PMID:15571967 doxorubicin decreases expression ISO FKBP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of FKBP5 mRNA CTD PMID:29803840 doxorubicin increases expression ISO Fkbp5 (Mus musculus) 6480464 Doxorubicin results in increased expression of FKBP5 mRNA CTD PMID:25896364 edaravone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] CTD PMID:31344373 entinostat increases expression ISO FKBP5 (Homo sapiens) 6480464 entinostat results in increased expression of FKBP5 mRNA CTD PMID:26272509 and PMID:27188386 entinostat multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP5 mRNA CTD PMID:27188386 enzalutamide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [enzalutamide co-treated with NVP-BHG712] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32184358 enzalutamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 enzalutamide results in decreased expression of FKBP5 mRNA CTD PMID:32184358 enzyme inhibitor multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FKBP5 protein CTD PMID:23301498 epoxiconazole affects expression ISO Fkbp5 (Mus musculus) 6480464 epoxiconazole affects the expression of FKBP5 mRNA CTD PMID:35436446 ethanol affects expression ISO Fkbp5 (Mus musculus) 6480464 Ethanol affects the expression of FKBP5 mRNA CTD PMID:30319688 folic acid multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FKBP5 mRNA CTD PMID:22206623 folpet increases expression ISO Fkbp5 (Mus musculus) 6480464 folpet results in increased expression of FKBP5 mRNA CTD PMID:31558096 fulvestrant multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Bucladesine co-treated with fulvestrant] results in decreased expression of FKBP5 mRNA more ... CTD PMID:26427651 furan increases expression EXP 6480464 furan results in increased expression of FKBP5 mRNA CTD PMID:26194646 genistein decreases expression EXP 6480464 Genistein results in decreased expression of FKBP5 mRNA CTD PMID:23160963 glafenine increases expression EXP 6480464 Glafenine results in increased expression of FKBP5 mRNA CTD PMID:24136188 glycidol increases expression EXP 6480464 glycidol results in increased expression of FKBP5 mRNA CTD PMID:24915197 glycochenodeoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 glycocholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA more ... CTD PMID:32152650 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 glyphosate decreases expression ISO Fkbp5 (Mus musculus) 6480464 glyphosate results in decreased expression of FKBP5 protein CTD PMID:37208198 graphene oxide increases expression ISO Fkbp5 (Mus musculus) 6480464 graphene oxide results in increased expression of FKBP5 mRNA CTD PMID:33227293 hexadecanoic acid decreases phosphorylation ISO FKBP5 (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of FKBP5 protein CTD PMID:28073184 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 indometacin multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FKBP5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FKBP5 mRNA CTD PMID:28628672 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of FKBP5 mRNA CTD PMID:20097248 isoprenaline increases expression ISO Fkbp5 (Mus musculus) 6480464 Isoproterenol results in increased expression of FKBP5 mRNA CTD PMID:20003209 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of FKBP5 mRNA CTD PMID:22641619 lead diacetate increases methylation EXP 6480464 lead acetate results in increased methylation of FKBP5 gene CTD PMID:29571894 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of FKBP5 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:21034739 and PMID:35811015 lipopolysaccharide increases expression ISO FKBP5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of FKBP5 mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of FKBP5 protein CTD PMID:21034739 maneb multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of FKBP5 mRNA CTD PMID:18386188 medroxyprogesterone acetate increases expression ISO FKBP5 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of FKBP5 mRNA CTD PMID:19146866 and PMID:20843944 mercury dibromide decreases expression ISO FKBP5 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of FKBP5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FKBP5 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FKBP5 mRNA CTD PMID:30467583 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of FKBP5 mRNA CTD PMID:16005536 methylarsonic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA CTD PMID:23192986 methylseleninic acid affects expression ISO FKBP5 (Homo sapiens) 6480464 methylselenic acid affects the expression of FKBP5 mRNA CTD PMID:14617803 mifepristone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:17690134 mono(2-ethylhexyl) phthalate decreases expression ISO Fkbp5 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of FKBP5 mRNA CTD PMID:22401849 N-acetyl-L-cysteine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of FKBP5 mRNA] CTD PMID:18829485 N-methyl-4-phenylpyridinium decreases expression ISO Fkbp5 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FKBP5 protein CTD PMID:26558463 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FKBP5 mRNA CTD PMID:18164116 naphthalene increases expression ISO Fkbp5 (Mus musculus) 6480464 naphthalene results in increased expression of FKBP5 mRNA CTD PMID:18978301 nefazodone decreases expression ISO FKBP5 (Homo sapiens) 6480464 nefazodone results in decreased expression of FKBP5 mRNA CTD PMID:32152650 nefazodone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FKBP5 mRNA CTD PMID:32152650 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of FKBP5 mRNA and Nevirapine results in increased expression of FKBP5 mRNA CTD PMID:23947594 niclosamide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Niclosamide results in decreased expression of FKBP5 mRNA CTD PMID:28500234 niclosamide multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA CTD PMID:28500234 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of FKBP5 mRNA CTD PMID:30449730 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FKBP5 mRNA CTD PMID:25729387 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of FKBP5 mRNA CTD PMID:23439660 ozone increases expression ISO Fkbp5 (Mus musculus) 6480464 Ozone results in increased expression of FKBP5 mRNA CTD PMID:17460151 and PMID:19555225 ozone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FKBP5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FKBP5 mRNA CTD PMID:34911549 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FKBP5 mRNA CTD PMID:37047376 ozone increases expression EXP 6480464 Ozone results in increased expression of FKBP5 mRNA CTD PMID:28623178 more ... paracetamol affects expression ISO Fkbp5 (Mus musculus) 6480464 Acetaminophen affects the expression of FKBP5 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FKBP5 mRNA CTD PMID:32479839 paracetamol decreases expression ISO FKBP5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FKBP5 mRNA CTD PMID:29067470 paraquat increases expression ISO Fkbp5 (Mus musculus) 6480464 Paraquat results in increased expression of FKBP5 mRNA CTD PMID:12595580 and PMID:21463325 paraquat multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of FKBP5 mRNA CTD PMID:18386188 paraquat affects expression EXP 6480464 Paraquat affects the expression of FKBP5 mRNA CTD PMID:16854511 parathion increases expression ISO Fkbp5 (Mus musculus) 6480464 Parathion results in increased expression of FKBP5 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO Fkbp5 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of FKBP5 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO FKBP5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of FKBP5 mRNA CTD PMID:27153767 perfluorooctanoic acid multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of FKBP5 mRNA CTD PMID:33325755 phenobarbital increases expression ISO Fkbp5 (Mus musculus) 6480464 Phenobarbital results in increased expression of FKBP5 mRNA CTD PMID:19270015 phenobarbital affects expression ISO FKBP5 (Homo sapiens) 6480464 Phenobarbital affects the expression of FKBP5 mRNA CTD PMID:19159669 phenylmercury acetate decreases expression ISO FKBP5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of FKBP5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FKBP5 mRNA CTD PMID:27188386 phlorizin decreases expression ISO Fkbp5 (Mus musculus) 6480464 Phlorhizin results in decreased expression of FKBP5 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO FKBP5 (Homo sapiens) 6480464 BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA] CTD PMID:20858459 phorbol 13-acetate 12-myristate increases expression ISO FKBP5 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA CTD PMID:20858459 phytoestrogen multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of FKBP5 mRNA CTD PMID:33325755 picoxystrobin increases expression ISO FKBP5 (Homo sapiens) 6480464 picoxystrobin results in increased expression of FKBP5 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO Fkbp5 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of FKBP5 mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO Fkbp5 (Mus musculus) 6480464 pirinixic acid results in increased expression of FKBP5 mRNA CTD PMID:18301758 more ... pregnenolone 16alpha-carbonitrile increases expression ISO Fkbp5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of FKBP5 mRNA CTD PMID:28903501 progesterone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA more ... CTD PMID:17404688 more ... progesterone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of FKBP5 mRNA CTD PMID:19693291 progesterone increases expression ISO FKBP5 (Homo sapiens) 6480464 Progesterone results in increased expression of FKBP5 mRNA CTD PMID:17404688 more ... quinomethionate affects expression ISO FKBP5 (Homo sapiens) 6480464 quinomethionate affects the expression of FKBP5 mRNA CTD PMID:15387888 raloxifene increases expression ISO FKBP5 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased expression of FKBP5 mRNA CTD PMID:22217510 resveratrol multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of FKBP5 mRNA CTD PMID:19167446 resveratrol increases expression ISO Fkbp5 (Mus musculus) 6480464 resveratrol results in increased expression of FKBP5 protein CTD PMID:25505154 rotenone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Rotenone results in decreased expression of FKBP5 mRNA CTD PMID:23186747 rotenone increases expression EXP 6480464 Rotenone results in increased expression of FKBP5 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FKBP5 mRNA CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of FKBP5 protein CTD PMID:23736079 SB 431542 multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO FKBP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of FKBP5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Fkbp5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of FKBP5 mRNA CTD PMID:23221170 and PMID:29341224 sodium arsenite increases expression ISO FKBP5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of FKBP5 mRNA CTD PMID:28595984 and PMID:34032870 sodium arsenite increases expression ISO Fkbp5 (Mus musculus) 6480464 sodium arsenite results in increased expression of FKBP5 mRNA CTD PMID:17682005 sodium arsenite multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of FKBP5 mRNA and [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of FKBP5 mRNA CTD PMID:23192986 and PMID:25873331 sodium dichromate decreases expression ISO Fkbp5 (Mus musculus) 6480464 sodium bichromate results in decreased expression of FKBP5 mRNA CTD PMID:22155349 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FKBP5 mRNA CTD PMID:22561333 and PMID:25993096 sodium fluoride decreases expression ISO Fkbp5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of FKBP5 protein CTD PMID:28918527 tacrolimus hydrate multiple interactions ISO Fkbp5 (Mus musculus) 6480464 Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein] CTD PMID:15697228 tamibarotene decreases expression ISO FKBP5 (Homo sapiens) 6480464 tamibarotene results in decreased expression of FKBP5 mRNA CTD PMID:15498508 tamoxifen affects expression ISO Fkbp5 (Mus musculus) 6480464 Tamoxifen affects the expression of FKBP5 mRNA CTD PMID:20937368 testosterone multiple interactions ISO FKBP5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FKBP5 mRNA CTD PMID:21592394 testosterone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of FKBP5 mRNA CTD PMID:33848595 testosterone multiple interactions ISO Fkbp5 (Mus musculus) 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO Fkbp5 (Mus musculus) 6480464 Testosterone results in increased expression of FKBP5 mRNA CTD PMID:19693291 and PMID:20403060 testosterone increases expression ISO FKBP5 (Homo sapiens) 6480464 Testosterone results in increased expression of FKBP5 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FKBP5 mRNA] CTD PMID:20032058 testosterone enanthate affects expression ISO FKBP5 (Homo sapiens) 6480464 testosterone enanthate affects the expression of FKBP5 mRNA CTD PMID:17440010 tetrachloroethene increases expression ISO Fkbp5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of FKBP5 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FKBP5 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Fkbp5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FKBP5 mRNA CTD PMID:31919559 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene CTD PMID:33854195 tibolone increases expression ISO FKBP5 (Homo sapiens) 6480464 tibolone results in increased expression of FKBP5 mRNA CTD PMID:22217510 tioguanine increases expression EXP 6480464 Thioguanine results in increased expression of FKBP5 mRNA CTD PMID:16005536 titanium dioxide decreases expression ISO Fkbp5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of FKBP5 mRNA CTD PMID:19464567 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of FKBP5 mRNA CTD PMID:30012374 titanium dioxide increases expression ISO Fkbp5 (Mus musculus) 6480464 titanium dioxide results in increased expression of FKBP5 mRNA CTD PMID:27760801 and PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FKBP5 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FKBP5 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of FKBP5 gene CTD PMID:27618143 triclosan decreases expression ISO FKBP5 (Homo sapiens) 6480464 Triclosan results in decreased expression of FKBP5 mRNA CTD PMID:30510588 Triptolide decreases expression ISO Fkbp5 (Mus musculus) 6480464 triptolide results in decreased expression of FKBP5 mRNA CTD PMID:32835833 triptonide decreases expression ISO Fkbp5 (Mus musculus) 6480464 triptonide results in decreased expression of FKBP5 mRNA CTD PMID:33045310 urethane increases expression ISO FKBP5 (Homo sapiens) 6480464 Urethane results in increased expression of FKBP5 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of FKBP5 mRNA CTD PMID:24136188 valproic acid decreases expression ISO Fkbp5 (Mus musculus) 6480464 Valproic Acid results in decreased expression of FKBP5 mRNA CTD PMID:17292431 valproic acid affects expression ISO FKBP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of FKBP5 mRNA CTD PMID:25979313 valproic acid increases expression ISO FKBP5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FKBP5 mRNA CTD PMID:23179753 zearalenone decreases expression ISO Fkbp5 (Mus musculus) 6480464 Zearalenone results in decreased expression of FKBP5 mRNA CTD PMID:24412631